Pharma - HealthQuill

Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the US regulator after a volunteer developed a serious nerve disorder.

USFDA puts on hold influenza, Covid-19 trial vaccines of Novavax

Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the.

by HealthQuill
October 17, 2024
0 Comments

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future climate-related health threats, according to a statement from the University of Glasgow.

Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

by HealthQuill
October 16, 2024
0 Comments

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise in coronary artery diseases, according to UK-based data analytics and consulting company, GlobalData.

Drugs Medical Pharma

Coronary drug-eluting stent market to grow 4% in India till 2033: Report

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.

by HealthQuill
October 16, 2024
0 Comments

Casual use of mental health language often describes behaviours that do not correlate with actual conditions, under the impression that it is “trendy.”

Health Medical Opinion Pharma

Opinion: Casual mental health words spicing up normal chats not justifiable

By Aparna S October 16, 2024: Is it okay to use mental health words casually in everyday conversations? If you believe that this.

by HealthQuill
October 16, 2024
0 Comments

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug to treat seizures in a group of rare epilepsies.

Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

by HealthQuill
October 14, 2024
0 Comments

Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of new pandemics, and global readiness remains inadequate, according to the World Health Organization.

Drugs Health Pharma

Pandemic threat looms, nations unprepared to handle crisis: WHO

Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of.

by HealthQuill
October 14, 2024
0 Comments

Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target humans, but bacteria.

Drugs Health Pharma

`Toothbrushes, showerheads nurture human-friendly bacteria’

Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target.

by HealthQuill
October 13, 2024
0 Comments

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder in haemophilia patients.

Drugs Health Pharma

Pfizer’s drug to treat rare haemophilia disorder gets US regulator’s approval

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder.

by HealthQuill
October 13, 2024
0 Comments

Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally, according to a World Health Organization report.

Drugs Health Pharma

Vaccines against pathogens can cut global antibiotic usage by 22%

Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,.